← Back to Patent Explorer
US5169932A Expired / Lapsed US ⏱️ 0.0 years remaining

Gnrh analogs

Assignee: Salk Institute for Biological Studies
•
Filing: 1990-06-27
•
Granted: 1992-12-08
•
Expires: 2010-06-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Peptides which include unnatural amino acides and which either inhibit or promote the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount of such peptides that are GnRH antagonists prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The antagonists may be used to treat steroid-dependent tumors, such as prostatic and mammary tumors. The peptides are analogs of the decapeptide GnRH wherein there is at least one residue of an unnatural amino acid in the 3-position, the 5-position, the 6-position and/or the 8-position. Such unnatural amino acids are useful in the synthesis of peptides and have the formula U*: ##STR1## where n is an integer from 1 to 6; Y is N--CN, N--CONHR 9 , S, O or CH--NO 2 ; R 9 is H, Ac, lower alkyl, aromatic or heterocyclic; X is NH, O, S, M 1 (CH q ) p M 2 or M 1 --(CH 2 ) p' --M 2 (CH 2 ) p" --M 3 , where M 1 is NR 10 , O, S or CHR 3 wherein R 3 is methyl, ethyl, propyl, phenyl, pyridinyl, pyrimidinyl or purinyl, q is 1 or 2; p, p' and p" are integers between O and 6; R 10 is H, lower alkyl or the like, and M 2 and M 3 are M 1 , COOH, CONH 2 , COOR 3 or CN; R 1 is H, alkyl, modified alkyl, alkenyl, alkynyl, aryl or a direct bond to X; R 2 is R 1 , OH, NH 2 , NHR 1 , or heterocycle.

Inventors

  • 👤 Carl A. Hoeger
  • 👤 Jean E. F. Rivier
  • 👤 Paula G. Theobald
  • 👤 John S. Porter
  • 👤 Catherine L. Rivier
  • 👤 Wylie W. Vale, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 06:51
CPC Classifications
C; C07; C07K; C07K14/00; C07K7/00; C07K7/04; C07K7/23; C07C; C07C279/00; C07C279/20; C07C279/24; C07C279/28; C07C313/00; C07C313/08; C07C313/18; C07C313/26; C07C313/30; C07D; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/14; C07K7/02; A; A61; A61K; A61K38/00; C07C2601/00; C07C2601/12; C07C2601/14; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/11

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 95 words
A peptide or a nontoxic salt thereof, said peptide having the formula: Ac-AA 1 -(A)D-Phe-AA 3 -Ser-AA 5 -AA 6 -Leu-AA 8 -Pro-D-Ala-NH 2 wherein AA 1 is β-D-2NAL or dehydroPro; A is 4Cl or 4F; AA 3 is D-Lys(icg), D-Lys(bcg), D-Lys(amp), D-3PAL, β-D-2NAL or D-Trp; AA 5 is Lys(cpd), Tyr, Arg, Lys(bcg), Lys(amp) or Lys(icg); AA 6 is D-Lys(bcg), D-Lys(icg), D-Lys(amp), D-Arg, β-D-2NAL or D-Lys(cpd); and AA 8 is ILys or Arg, provided however that at least one of residues AA 3 , AA 5 , and AA 6 has a cyanoguanidino side chain.
Claim 2
Dependent Claim 95 words
A peptide or a nontoxic salt thereof, said peptide having the formula: Ac-AA 1 -(A)D-Phe-AA 3 -Ser-AA 5 -AA 6 -Leu-AA 8 -Pro-D-Ala-NH 2 wherein AA 1 is β-D-2NAL or dehydroPro; A is 4Cl or 4F; AA 3 is D-Lys(icg), D-Lys(bcg), D-Lys(amp), D-3PAL, β-D-2NAL or D-Trp; AA 5 is Lys(cpd), Tyr, Arg, Lys(bcg), Lys(amp) or Lys(icg); AA 6 is D-Lys(bcg), D-Lys(icg), D-Lys(amp), D-Arg, β-D-2NAL or D-Lys(cpd); and AA 8 is ILys or Arg, provided however that at least one of residues AA 3 , AA 5 , and AA 6 has a cyanoguanidino side chain.
Claim 3
Dependent Claim 21 words
A peptide in accordance with claim 1 wherein AA 5 is Lys(icg), AA 6 is D-Lys(icg) and AA 8 is Arg.
Claim 4
Dependent Claim 21 words
A peptide in accordance with claim 1 wherein AA 5 is Lys(icg), AA 6 is D-Lys(icg) and AA 8 is ILys.
Claim 5
Dependent Claim 19 words
A peptide or a nontoxic salt thereof in accordance with claim 1 having the formula Ac-β-D-2NAL-(4Cl)D-Phe-D-3PAL-Ser-Lys(icg)-D-Lys(icg)-Leu-ILys-Pro-D-Ala -NH 2 .
Claim 6
Dependent Claim 19 words
A peptide or a nontoxic salt thereof in accordance with claim 1 having the formula Ac-β-D-2NAL-(4Cl)D-Phe-D-3PAL-Ser-Lys(bcg)-D-Lys(bcg)-Leu-Arg-Pro-D-Ala -NH 2 .
Claim 7
Dependent Claim 18 words
A peptide or a nontoxic salt thereof in accordance with claim 1 having the formula Ac-β-D-2NAL-(4Cl)D-Phe-D-Lys(bcg)-Ser-Tyr-D-Arg-Leu-ILys-Pro-D-Ala-NH 2 .
Claim 8
Dependent Claim 18 words
A peptide or a nontoxic salt thereof in accordance with claim 1 having the formula Ac-β-D-2NAL-(4Cl)D-Phe-D-Lys(bcg)-Ser-Tyr-D-Arg-Leu-ILys-Pro-D-Ala-NH 2 .

References Cited (Backward Citations)

US4234571A Cited
US4698442A Cited
US4801577A Cited
US4935491A Cited
US4815385A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-12-08 1996-06-08 1996-12-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-12-08 2000-06-08 2000-12-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-12-08 2004-06-08 2004-12-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag